Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hot Products

Hengrui's Application for New Class 1.1 Drug Hetrombopag Ethanolamine Tablets was Accepted by CDE

PharmaSources/DopineJune 19, 2020

Tag: Hengrui , Class 1.1 , new drug , Hetrombopag ethanolamine tablets

PharmaSources Customer Service